A randomized, open-label, parallel-design, multicenter, Phase III study to compare the safety and efficacy of a fixed dose combination of SULBACTOMAX Vs CEFTRIAXONE in the treatment of hospitalized adult patients with Community-Acquired Pneumonia
100 项与 KOREA PHARMA Co., Ltd. 相关的临床结果
0 项与 KOREA PHARMA Co., Ltd. 相关的专利(医药)
100 项与 KOREA PHARMA Co., Ltd. 相关的药物交易
100 项与 KOREA PHARMA Co., Ltd. 相关的转化医学